Blog
RSS FeedPosted by Michael Wonder on 23 Nov 2016
Halaven cleared by TGA for sarcoma
23 November 2016 - Eisai bags a second use for its halichondrin B analogue. ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves another Opdivo for another cancer type
23 November 2016 - The TGA has sanctioned the use of nivolumab for use by patients with renal cell carcinoma. ...
Posted by Michael Wonder on 20 Nov 2016
TGA approves Grifols' Prolastin C
17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor. ...
Posted by Michael Wonder on 17 Nov 2016
TGA approves Ninlaro
17 November 2016 - The TGA has approved Takeda's proteasome inhibitor for use by patients with multiple myeloma. ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves new combination product for type 2 diabetes
31 October 2016 - The TGA has approved AstraZeneca's Qtern (saxagliptin hydrochloride with dapagliflozin propanediol monohydrate). ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves yet another use for Humira (adalimumab)
31 October 2016 - AbbVie clocks up another indication for its TNF-alfa inhibitor. ...
Posted by Michael Wonder on 30 Sep 2016
Fast-track approval of medicines in Australia
30 September 2016 - The Australian Government has recently taken steps to fast track the registration of new medicines, generics, and ...
Posted by Michael Wonder on 27 Sep 2016
Idelvion now registered in Australia
27 September 2016 - CSL Behring's Idelvion is now approved by the TGA. ...
Posted by Michael Wonder on 27 Sep 2016
Zinbryta approved by TGA
27 September 2016 - The TGA has approved Biogen's Zinbryta. ...
Posted by Michael Wonder on 27 Sep 2016
TGA approves new use for Takeda's Adcetris
27 September 2016 - The TGA has approved a new use for Takeda's CD 30 receptor antagonist. ...
Posted by Michael Wonder on 15 Sep 2016
TGA approves Simponi for axial spondyloarthritis
15 September 2016 - The TGA has approved a new use for Simponi. ...
Posted by Michael Wonder on 15 Sep 2016
TGA approves new indication for Alprolix
15 September 2016 - The TGA has approved a new use for Biogen's Alprolix. ...
Posted by Michael Wonder on 14 Sep 2016
TGA approves Odefsey
30 August 2016 - The TGA has approved Gilead's combination product for HIV-1 infection Odefsey. ...
Posted by Michael Wonder on 14 Sep 2016
TGA approves Taltz
14 September 2016 - The TGA has approved Eli Lilly's Taltz (ixekizumab). ...
Posted by Michael Wonder on 05 Sep 2016
TGA approves new indication for Gazyva
5 September 2016 - The TGA has approved a new use for Roche's CD20 receptor antagonist. ...